When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TAK - Poseida Therapeutics: Genome Engineering For Safer Cell Therapies
Takeda Pharmaceutical Company Limited American Depositary Shares
Poseida has built a non-viral genome engineering platform to develop safer cell therapies in oncology.
This platform could enable outpatient use and expand the number of patients who can receive a cell therapy as well as bringing in substantial partnerships.
Poseida's lead drug candidate, P-BCMA-101, has shown outstanding safety in a Phase 1 trial but needs more data on its efficacy.
As a result, we recommend monitoring the stock until more data is released for the expanded Phase 1 trial for Poseida's lead asset.